PIK3CA and osteosarcoma: GPNMB may also be a potential target for targeted therapy of osteosarcoma, as it has been found that GPNMB can regulate the metastasis and proliferation of osteosarcoma cells by affecting the PI3K/AKT/mTOR pathway (92).